Humana (HUM) PT Lowered to $415 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HUM Hot Sheet
Price: $425.24 +1.76%
Rating Summary:
19 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
19 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Oppenheimer analyst Michael Wiederhorn lowered the price target on Humana (NYSE: HUM) to $415.00 (from $630.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Humana and athenahealth expand electronic prior authorization capabilities nationwide, reducing administrative burden for physicians and helping patients access care faster
- Bruker (BRKR) PT Raised to $70 at Jefferies
- Revvity Inc (RVTY) PT Raised to $177 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
